Get the Stockscreener App
25.91
0.61%
-0.16
Pre-market:
26.10
0.19
+0.73%
Centene Corp stock is traded at $25.91, with a volume of 17.52M.
It is down -0.61% in the last 24 hours and down -54.26% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$26.07
Open:
$26.2
24h Volume:
17.52M
Relative Volume:
1.47
Market Cap:
$12.89B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
4.1522
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
-8.74%
1M Performance:
-54.26%
6M Performance:
-59.53%
1Y Performance:
-66.74%
1-Day Range:
$25.52
$26.55
1-Week Range:
$25.11
$28.37
52-Week Range:
$25.11
$80.59
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
25.91 | 12.80B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
237.77 | 226.39B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
62.47 | 78.76B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
262.23 | 71.36B | 261.22B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
274.66 | 63.74B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
247.26 | 30.05B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Does Centene Corporation stock perform well during market downturnsMaximize your portfolio’s growth potential - jammulinksnews.com
What catalysts could drive Centene Corporation stock higher in 2025Stay ahead with advanced stock screening tools - jammulinksnews.com
ROSEN, A LEADING NATIONAL FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC - GlobeNewswire Inc.
How volatile is Centene Corporation stock compared to the marketHigh-margin investment plays - jammulinksnews.com
What institutional investors are buying Centene Corporation stockAchieve rapid portfolio growth with smart picks - jammulinksnews.com
What are Centene Corporation company’s key revenue driversAchieve exceptional returns with expert guidance - jammulinksnews.com
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
CNC Investors Have Opportunity To Lead Centene Corporation Securities Fraud Lawsuit - Barchart.com
Centene Corporation (CNC) Faces Shareholder Ire Amidst - GlobeNewswire
Centene Shareholder Sues Board Over Revoked Earnings Forecast - Bloomberg Law News
Centene Corporation (CNC)’s “One Of The Most Horrible Stocks In The Group,” Says Jim Cramer - Insider Monkey
Meridian and the Centene Foundation Announce $1 Million Grant to the Food Bank Council of Michigan - Financial Times
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Centene Corporation(CNC) Shareholders - Barchart.com
CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
Oppenheimer Initiates Outperform on Centene, Sees Turnaround Potential After Guidance Shock - Insider Monkey
Truist Lowers Centene PT to $35 Despite Stronger PDP, Medicare Advantage Performance - Insider Monkey
Centene Launches Game-Changing Mobile Health Clinic Program Reaching Thousands of Hawaii Students - Stock Titan
Peach State Health Plan Builds Upon Community Partnership with Barrow County Schools to Support Student Health and Readiness – Company AnnouncementFT.com - Financial Times
Centene director Samuels buys $248k in company stock - Investing.com
Centene director Samuels buys $248k in company stock By Investing.com - Investing.com South Africa
Centene Corporation (NYSE:CNC) Q2 2025 Earnings Call Transcript - Insider Monkey
Centene (CNC): Company Profile, Stock Price, News, Rankings - Fortune
Centene Corp. stock underperforms Monday when compared to competitors - MarketWatch
Class Action Filed Against Centene CorporationSeptember 8, 2025 Deadline to JoinContact Faruqi & Faruqi - Stockhouse
$16M Centene Healthcare Center Opens in Uvalde with Comprehensive Services | CNC Stock News - Stock Titan
Centene Corporation (CNC) Cuts Outlook After $1.8B ACA Revenue Hit - Insider Monkey
Tapestry To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
UBS Reduces Price Target for Centene (CNC), Maintains Neutral Ra - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Cantor Fitzgerald downgrades Centene stock rating to Neutral on HIX uncertainty - Investing.com
Centene Slashes 2025 Guidance and Posts Surprise Loss - Mint
What is the risk reward ratio of investing in Centene Corporation stockInvest confidently with real-time market updates - jammulinksnews.com
How strong is Centene Corporation company’s balance sheetAchieve exceptional returns with expert guidance - jammulinksnews.com
CNC Investors with Losses Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit - Barchart.com
CNC INVESTOR ALERT: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Centene Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
CNC STOCK REMINDER: BFA Law Reminds Centene Corporation Investors with Losses to Contact the Firm by September 8 Legal Deadline - Newsfile
Why Centene Corporation stock attracts strong analyst attentionReal Time Breakout Tracking - metal.it
Centene stock plunges after surprise loss and soaring medical costs - MSN
Centene reports a rare loss as medical costs surge, and the stock hits a decade low - MSN
Centene Reports Loss, Citing Rising Medical Costs - The Wall Street Journal
Centene: Q2 Earnings Snapshot - CTPost
Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises - Investing.com
Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises By Investing.com - Investing.com South Africa
Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for ... - Yahoo Finance
Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for Future Profitability - GuruFocus
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene bounces back after surprise quarterly loss sent it plunging in pre-market trading - Sherwood News
Centene (CNC) Shares Drop After Q2 Earnings Miss Expectations - GuruFocus
Centene posts big loss in second quarter amid federal health care cuts - STLtoday.com
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):